Burning Rock Biotech gains on 2022 revenue growth forecast raise

Burning Rock Biotech

18/01/2023 15:39

** Shares of China-based firm Burning Rock Biotech Ltd
 BNR.O  rise ~6% to $3.67 
    ** Late Tuesday, co said it expected full-year revenue
growth of ~10% in 2022, up from 5% it expected previously 
    ** Raise in outlook driven by better Q4 performance than
previously estimated - company
    ** Stock up 75% in the past 3 months
 (Reporting by Raghav Mahobe)
 ((Raghav.Mahobe@thomsonreuters.com;))